Verteporfin Market
According to Intent Market Research, the Verteporfin Market is expected to grow from USD 0.5 billion in 2024-e at a CAGR of 13.6% to touch USD 1.0 billion by 2030. The Verteporfin Market is dominated by key players such as, Bausch & Lomb Incorporated, Novartis AG, Alcon Laboratories, Inc., Bayer AG, and Genentech, Inc. (Roche Group).